Eli Lilly’s Alzheimer’s treatment approved in China
(Reuters) – China’s medical regulator has approved Eli Lilly (NYSE:LLY)’s treatment for early Alzheimer’s, providing patients with another option after Eisai and
(Reuters) – China’s medical regulator has approved Eli Lilly (NYSE:LLY)’s treatment for early Alzheimer’s, providing patients with another option after Eisai and
Investing.com– Australia’s Insignia Financial has rejected a A$2.67 billion ($1.69 billion) takeover bid from Bain Capital, saying the offer does not provide fair
By David Shepardson WASHINGTON (Reuters) -The U.S. Transportation Department on Tuesday finalized its awards of five new daily round-trip flights from Washington Reagan
Investing.com– Eli Lilly and Company (NYSE:LLY) said on Tuesday evening that China’s food and drug regulator had approved its Kisunla treatment for early
By Giuseppe Fonte and Giulio Piovaccari ROME (Reuters) -Fiat-maker Stellantis (NYSE:STLA) on Tuesday presented an upbeat plan to revitalise its output in Italy,
Investing.com– Shares of Nissan) and Mitsubishi Motors)rose sharply on Wednesday after media reports said Honda and Nissan (OTC:NSANY) were considering a three-way
Investing.com– Stifel downgraded its rating on Electronic Arts Inc (NASDAQ:EA), stating that while the stock did mark strong returns in
TOKYO (Reuters) – Bain Capital plans to launch a tender offer for Fuji Soft shares even without the approval of the target
By Chuck Mikolajczak NEW YORK (Reuters) -U.S. stocks retreated on Tuesday and the Dow dropped for a ninth straight session, as investors exercised
Some lawmakers in the new Congressional DOGE Caucus are eyeing a crackdown on federal agencies work-from-home policies when Republicans take over the